Cyclopentobarbital
In today's world, Cyclopentobarbital has been a topic of constant debate and analysis. From its origins to its relevance in modern society, Cyclopentobarbital has captured the attention of academics, experts, and the general public. With a rich and varied history, Cyclopentobarbital has played a fundamental role in the development of humanity, influencing different aspects of daily life. Over the years, its impact has been so significant that it continues to be an object of study and reflection in different areas. In this article, we will further explore the role of Cyclopentobarbital and its importance in today's world.
 | |
| Clinical data | |
|---|---|
| Other names | Allylpental, Cyclopental, 5-Allyl-5-Δ2-Cyclopentenyl Barbituric Acid |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ECHA InfoCard | 100.000.891 |
| Chemical and physical data | |
| Formula | C12H14N2O3 |
| Molar mass | 234.255 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Cyclopentobarbital sodium (Cyclopal, Dormisan) is a barbiturate derivative invented in the 1940s. It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine. Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.
See also
References
- ^ Martin JR, Godel T, Hunkeler W, Jenck F, Moreau JL, Sleight AJ, Widmer U (December 2000). "Psychopharmacological agents.". Kirk-Othmer Encyclopedia of Chemical Technology. doi:10.1002/0471238961.1619250313011820.a01. ISBN 0471238961.
- ^ Vander Brook MJ, Cartland GF (1944). "A Pharmacologic Study of 5-Allyl-5-Cyclopentenyl Barbituric Acid (Cyclopal)". Journal of Pharmacology and Experimental Therapeutics. 80 (2): 119–125. CiteSeerX 10.1.1.983.6071.
 | This sedative-related article is a stub. You can help Wikipedia by expanding it. |